Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for benign prostatic enlargement
Hong Kong Medical Journal · 18.06.2026
DOI: 10.12809/hkmj2513308 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Hong Kong Medical Journal, online erschienen am 18.06.2026. Verfasst von C F Ng und 10 weiteren Autor:innen. Beteiligte Einrichtung: SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Mass Screening, Prostatic Hyperplasia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
- Lithotripsy and Uro-investigation Centre, Prince of Wales Hospital, Hong Kong SAR, China.
- Day Surgery Centre, Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, China.
Zitieren
APA
Ng, C. F., Chan, C. K., Yuen, S. K. K., Kwok, H. S. W., Wu, I. P. H., Wang, J., Lai, F. P. T., Lo, A. K. L., Liu, A. Q., Chiu, P. K. F., & Teoh, J. Y. C. (2026). Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for benign prostatic enlargement. Hong Kong Medical Journal. https://doi.org/10.12809/hkmj2513308
Vancouver
Ng CF, Chan CK, Yuen SKK, Kwok HSW, Wu IPH, Wang J, et al. Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for benign prostatic enlargement. Hong Kong Medical Journal. 2026. doi:10.12809/hkmj2513308
BibTeX
@article{Ng2026,
author = {Ng, C F and Chan, C K and Yuen, S K K and Kwok, H S W and Wu, I P H and Wang, J and Lai, F P T and Lo, A K L and Liu, A Q and Chiu, P K F and Teoh, J Y C},
title = {Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for benign prostatic enlargement},
journal = {Hong Kong Medical Journal},
year = {2026},
doi = {10.12809/hkmj2513308}
}
EUVIMED